VivoSim Labs (FRA:4OR) EPS (Basic): €1.83 (TTM As of Dec. 2025)

What is VivoSim Labs EPS (Basic)?

VivoSim Labs FRA:4OR 39 EPS (Basic) is €1.83 as of Dec. 2025. GuruFocus rates FRA:4OR with a GF Score™ of 39/100 and a GF Value™ of €8.13. The stock has 4 warning signs investors should review.

VivoSim Labs's basic earnings per share (Basic EPS) for the three months ended in Dec. 2025 was €-0.88. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was €1.83.

VivoSim Labs's EPS (Diluted) for the three months ended in Dec. 2025 was €-0.88. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €1.83.

VivoSim Labs's EPS without NRI for the three months ended in Dec. 2025 was €-0.88. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 1.83.

During the past 3 years, the average EPS without NRI Growth Rate was 23.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was 22.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 22.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, VivoSim Labs's highest 3-Year average EPS without NRI Growth Rate was 34.00% per year. The lowest was -533.40% per year. And the median was 13.00% per year.

VivoSim Labs (FRA:4OR) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

VivoSim Labs EPS (Basic) Related Terms

VivoSim Labs EPS (Basic) Historical Data

* Premium members only.

The historical data trend for VivoSim Labs's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VivoSim Labs EPS (Basic) Chart

VivoSim Labs Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

EPS (Basic)

Get a 7-Day Free Trial

-24.60

-14.38

-22.19

-17.71

-1.57

VivoSim Labs Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25
EPS (Basic)	Get a 7-Day Free Trial															-2.18	4.53	-0.99	-0.84	-0.88

39GF Score

VivoSim Labs Inc FRA:4OR

EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

VivoSim Labs EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

VivoSim Labs's Basic EPS for the fiscal year that ended in Mar. 2025 is calculated as

Basic EPS (A: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-2.301	-	0)	/	1.464
	=	-1.57

VivoSim Labs's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-2.298	-	0)	/	2.608
	=	-0.88

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.83

Frequently Asked Questions Learn more about EPS (Basic) →

What does a EPS (Basic) of €1.83 mean?

VivoSim Labs (FRA:4OR) has a EPS (Basic) of €1.83 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on VivoSim Labs and its competitors.

Is VivoSim Labs' EPS (Basic) too high?

VivoSim Labs' current EPS (Basic) is €1.83. Overall, VivoSim Labs has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.

How does VivoSim Labs' EPS (Basic) compare to AZTR and GRI?

VivoSim Labs' EPS (Basic) of €1.83 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EPS (Basic) for a Biotechnology company?

A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EPS (Basic) mean?

A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on VivoSim Labs and its competitors. VivoSim Labs's current EPS (Basic) is €1.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is VivoSim Labs stock overvalued right now?

VivoSim Labs (FRA:4OR) has a current EPS (Basic) of €1.83. The stock's GF Value™ is €8.13, compared to a current price of €3.49 — trading 57% below its estimated fair value. The current EPS (Basic) is €1.83. VivoSim Labs' overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EPS (Basic) calculated?

EPS (Basic) is calculated from a company's financial statements. For VivoSim Labs (FRA:4OR), the current EPS (Basic) is €1.83 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is VivoSim Labs (FRA:4OR) Overvalued in 2026?

Based on GuruFocus' analysis, VivoSim Labs stock appears to be undervalued. The current stock price of €3.49 is trading 57% below its estimated GF Value™ of €8.13.

Key valuation signals for FRA:4OR:

EPS (Basic): €1.83
GF Value™: €8.13 vs. price of €3.49 (57% below fair value)
GF Score™: 39/100 with 4 warning signs

No single metric tells the full story. See the FRA:4OR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

VivoSim Labs Business Description

Industry Healthcare Biotechnology

Comparable Companies AZTR GRI BIXT CMND SXTP CLDI LSBCF ACUT PPCB ENSC VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges VIVS:USA

Address 11555 Sorrento Valley road, Suite 100, San Diego, CA, USA, 92121

Website https://www.organovo.com

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

39GF Score

Get the complete analysis for FRA:4OR

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.49

Price

€8.13

GF Value

View FRA:4OR Analysis

See EPS (Basic) data for all stocks →